BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 31, 2009
View Archived Issues
Trubion, Facet Joining Forces on Early-Stage Leukemia Drug
Trubion Pharmaceuticals Inc. has entered collaboration with Facet Biotech Corp. to jointly develop Phase I TRU-016 for chronic lymphocytic leukemia, in a deal worth up to $206.5 million. (BioWorld Today)
Read More
Vion, Genzyme, Allos Nipped on FDA'S Review Pre-ODAC
Read More
Squabbling Over VC Loophole Leaves SBIR Program in Limbo
Read More
Protein-Only Theory of Prion Disease Gets New Support
Read More
Other News To Note
Read More
Clinic Roundup
Read More